Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8S9H

Crystal structure of monkey TLR7 ectodomain with compound 14

Summary for 8S9H
Entry DOI10.2210/pdb8s9h/pdb
DescriptorToll-like receptor 7, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (7 entities in total)
Functional Keywordstoll-like receptor 7, pattern recognition receptor, immune system, agonist
Biological sourceMacaca mulatta (Rhesus monkey)
Total number of polymer chains2
Total formula weight194255.46
Authors
Critton, D.A. (deposition date: 2023-03-28, release date: 2024-02-07, Last modification date: 2024-10-23)
Primary citationHe, L.,Zhang, M.Y.,Cox, M.,Zhang, Q.,Donnell, A.F.,Zhang, Y.,Tarby, C.,Gill, P.,Subbaiah, M.A.M.,Ramar, T.,Reddy, M.,Puttapaka, V.,Li, Y.X.,Sivaprakasam, P.,Critton, D.,Mulligan, D.,Xie, C.,Ramakrishnan, R.,Nagar, J.,Dudhgaonkar, S.,Murtaza, A.,Oderinde, M.S.,Schieven, G.L.,Mathur, A.,Gavai, A.V.,Vite, G.,Gangwar, S.,Poudel, Y.B.
Identification and Optimization of Small Molecule Pyrazolopyrimidine TLR7 Agonists for Applications in Immuno-oncology.
Acs Med.Chem.Lett., 15:189-196, 2024
Cited by
PubMed Abstract: Small molecule toll-like receptor (TLR) 7 agonists have gathered considerable interest as promising therapeutic agents for applications in cancer immunotherapy. Herein, we describe the development and optimization of a series of novel TLR7 agonists through systematic structure-activity relationship studies focusing on modification of the phenylpiperidine side chain. Additional refinement of ADME properties culminated in the discovery of compound , which displayed nanomolar reporter assay activity and favorable drug-like properties. Compound demonstrated excellent pharmacokinetic/pharmacodynamic profiles and synergistic antitumor activity when administered in combination with aPD1 antibody, suggesting opportunities of employing in immuno-oncology therapies with immune checkpoint blockade agents.
PubMed: 38352849
DOI: 10.1021/acsmedchemlett.3c00456
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.437 Å)
Structure validation

236371

PDB entries from 2025-05-21

PDB statisticsPDBj update infoContact PDBjnumon